Anne Marie Schou-Pedersen

Dr. Anne Marie Schou-Pedersen

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2018 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Open access
PDF file
DIDavid Ipsen
David Ipsen
BRBidda Rolin
Bidda Rolin
GRGünaj Rakipovski
Günaj Rakipovski
GSGry F. Skovsted
Gry F. Skovsted
AMAnette Madsen
Anette Madsen
PTPernille Tveden-Nyborg
Pernille Tveden-Nyborg
Although commonly associated with obesity, non‐alcoholic fatty liver disease (NAFLD) is also present in the lean population representing a unique disease phenotype. Affecting 25% of the world's population, NAFLD is associated with increased mortality especially when progressed to non‐alcoholic steatohepatitis (NASH). However, no approved pharmacological treatments exist. Current research focuses mainly on NASH associated with obesity, leaving the effectiveness of promising treatments in lean NASH virtually unknown. This study therefore aimed to evaluate the effect of liraglutide (glucagon‐like peptide 1 analogue) and dietary intervention, alone and in combination, in guinea pigs with non‐obese NASH. After 20 weeks of high‐fat feeding (20% fat, 15% sucrose, 0.35% cholesterol), 40 female guinea pigs were block‐randomized based on weight into four groups receiving one of four treatments for 4 weeks: continued high‐fat diet (HF, control), high‐fat diet and liraglutide treatment (HFL), chow diet (4% fat, 0% sucrose, 0% cholesterol; HFC) or chow diet and liraglutide treatment (HFCL). High‐fat feeding induced NASH with severe fibrosis. Liraglutide decreased inflammation (p < 0.05) and hepatocyte ballooning (p < 0.05), while increasing hepatic α‐tocopherol (p = 0.0154). Dietary intervention did not improve liver histopathology significantly, but decreased liver weight (p = 0.004), plasma total cholesterol (p = 0.0175), LDL‐cholesterol (p = 0.0063), VLDL‐cholesterol (p = 0.0034), hepatic cholesterol (p < 0.0001) and increased hepatic vitamin C (p = 0.0099). Combined liraglutide and dietary intervention induced a rapid weight loss, necessitating periodical liraglutide dose adjustment/discontinuation, limiting the strength of the findings from this group. Collectively, this pre‐clinical study supports the beneficial effect of liraglutide on NASH and extends this notion to lean NASH.

18 January 2017 in British Journal of Anaesthesia
Verified
Journal Article
Open access
PDF file
SES. Ekeloef
S. Ekeloef
MLMikkel Hjordt Holm Larsen
Mikkel Hjordt Holm Larsen
ASAnne Marie Schou-Pedersen
Anne Marie Schou-Pedersen
Jens LykkesfeldtJens Lykkesfeldt
Jens Lykkesfeldt
JRJ. Rosenberg
J. Rosenberg
Ismail GögenurIsmail Gögenur
Ismail Gögenur
Background. Evidence suggests that endothelial dysfunction in the early postoperative period promotes myocardial injury after non-cardiac surgery. The aim of this study was to investigate the impact of colon cancer surgery on endothelial function and the association with the l-arginine-nitric oxide pathway postoperatively. Methods. Patients undergoing elective colon cancer surgery (n = 31) were included in this prospective observational cohort study. Endothelial function, as measured using the reactive hyperaemia index (RHI), was assessed non-invasively using digital pulse tonometry. RHI and plasma concentrations of L-arginine, asymmetric dimethylarginine (ADMA), dihydrobiopterin and biopterin metabolites, tetrahydrobiopterin (BH4) and total biopterin were measured before surgery, at four h after surgery and at postoperative day one and two. Cardiac troponin I was measured before surgery and once daily on postoperative days one to four. Results. Preoperative RHI was 1.86 (1.64 – 2.11) and decreased significantly during the observation period (linear mixed effects model of serial measurements, P = 0.015). Both L-arginine (P < 0.001) and ADMA (P = 0.024) decreased during the postoperative period. All biopterin metabolites were significantly decreased after surgery. A significant positive correlation was found between logAUC(l-arginine/ADMA) and logAUC(RHI) (P = 0.015) and between logAUC(L-arginine/ADMA) and logAUC(BH4) (P = 0.015). None of the patients had cardiac troponin I elevations. Conclusions. RHI was attenuated in the first days after colon cancer surgery indicating acute endothelial dysfunction. Endothelial dysfunction correlated with disturbances in the L-arginine – nitric oxide pathway. Our findings provide a rationale for investigating the hypothesized association between acute endothelial dysfunction and cardiovascular complications after non-cardiac surgery. Clinical trial registration. NCT02344771.

1 January 2014 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
ASAnne Marie Schou-Pedersen
Anne Marie Schou-Pedersen
JOJesper Ostergaard
Jesper Ostergaard
MJMats Johansson
Mats Johansson
SDStephane Dubant
Stephane Dubant
RFRune B. Frederiksen
Rune B. Frederiksen
SHSteen Honoré Hansen
Steen Honoré Hansen

1 May 2018 in Neuroscience Letters
Verified
Journal Article
Open access
SHStine Normann Hansen
Stine Normann Hansen
DIDavid Ipsen
David Ipsen
ASAnne Marie Schou-Pedersen
Anne Marie Schou-Pedersen
Jens LykkesfeldtJens Lykkesfeldt
Jens Lykkesfeldt
PTPernille Tveden-Nyborg
Pernille Tveden-Nyborg
Western diets, high in fat and energy, are associated with cognitive deficits in humans and animal models, but the underlying mechanisms are not fully elucidated. This includes whether diet-induced dyslipidemia per se negatively impacts brain signaling. Here we investigate the effects of dyslipidemia induced by two high fat diets with or without high sucrose on hippocampal and frontal cortical oxidative stress, brain-derived neurotrophic factor (BDNF) and down-stream markers of synaptic plasticity, as well as alterations in monoaminergic neurotransmitter levels. A high fat diet was associated with decreased antioxidant status (vitamin C), increased serotonin in the frontal cortex, and increased ratio of phosphorylated Ca2+/calmodulin-dependent protein kinase II in the hippocampus, while a high fat and sucrose diet decreased levels of vitamin C in the frontal cortex and BDNF in the hippocampus. Markers of dyslipidemia correlated significantly with cerebral vitamin C levels, monoaminergic neurotransmitters and metabolites in the frontal cortex, but not in the hippocampus. Thus, a high fat diet caused regional alterations in antioxidant levels, neurochemistry and molecular markers in the non-obese dyslipidemic guinea pig.

19 November 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
JKJulie Hviid Klæbel
Julie Hviid Klæbel
MSMia Skjødt
Mia Skjødt
JSJosephine Skat-Rørdam
Josephine Skat-Rørdam
GRGünaj Rakipovski
Günaj Rakipovski
DIDavid Ipsen
David Ipsen
PTPernille Tveden-Nyborg
Pernille Tveden-Nyborg
Despite affecting millions of patients worldwide, no pharmacological treatment has yet proved effective against non-alcoholic steatohepatitis (NASH) induced liver fibrosis. Current guidelines recommend lifestyle modifications including reductions in dietary energy intake. Recently, therapy with atorvastatin and vitamin E (vitE) has been recommended, although clinical studies on the resolution of hepatic fibrosis are inconclusive. Targeting NASH-induced hepatic end-points, this study evaluated the effects of atorvastatin and vitE alone or in combination with a dietary intervention in the guinea pig NASH model. Guinea pigs (n = 72) received 20 weeks of high fat feeding before allocating to four groups: continued HF feeding (HF), HF diet with atorvastatin and vitE (HF+), low-fat diet (LF) and low-fat with atorvastatin and vitE (LF+), for four or eight weeks of intervention. Both LF and LF+ decreased liver weight, cholesterol and plasma dyslipidemia. LF+ further improved hepatic histopathological hallmarks (p < 0.05), liver injury markers aspartate aminotransferase (AST) and alanine aminotransferase (ALT) (p < 0.05) and reduced the expression of target genes of hepatic inflammation and fibrosis (p < 0.05), underlining an increased effect on NASH resolution in this group. Collectively, the data support an overall beneficial effect of diet change, and indicate that atorvastatin and vitE therapy combined with a diet change act synergistically in improving NASH-induced endpoints.

16 March 2020 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
SESarah Ekeloef
Sarah Ekeloef
JOJakob Ohm Oreskov
Jakob Ohm Oreskov
AFAndreas Falkenberg
Andreas Falkenberg
JBJakob Burcharth
Jakob Burcharth
ASAnne Marie Schou-Pedersen
Anne Marie Schou-Pedersen
IGIsmail Gögenur
Ismail Gögenur
Background: Preoperative endothelial dysfunction is a predictor of myocardial injury and major adverse cardiac events. Non-cardiac surgery is known to induce acute endothelial changes. The aim of this explorative cohort study was to assess the extent of systemic endothelial dysfunction after major emergency abdominal surgery and the potential association with postoperative myocardial injury. Methods: Patients undergoing major emergency abdominal surgery were included in this prospective cohort study. The primary outcome was the change in endothelial function expressed as the reactive hyperemia index from 4-24 h after surgery until postoperative day 3–5. The reactive hyperemia index was assessed by non-invasive digital pulse tonometry. Secondary outcomes included changes in biomarkers of nitric oxide metabolism and bioavailability. All assessments were performed at the two separate time points in the postoperative period. Clinical outcomes included myocardial injury within the third postoperative day and major adverse cardiovascular events within 30 days of surgery. Results: Between October 2016 and June 2017, 83 patients were included. The first assessment of the endothelial function, 4–24 h, was performed 15.8 (SD 6.9) hours after surgery and the second assessment, postoperative day 3–5, was performed 83.7 (SD 19.8) hours after surgery. The reactive hyperemia index was suppressed early after surgery and did not increase significantly; 1.64 (95% CI 1.52–177) at 4–24 h after surgery vs. 1.75 (95% CI 1.63–1.89) at postoperative day 3–5, p = 0.34. The L-arginine/ADMA ratio, expressing the nitric oxide production, was reduced in the perioperative period and correlated significantly with the reactive hyperemia index. A total of 16 patients (19.3%) had a major adverse cardiovascular event, of which 11 patients (13.3%) had myocardial injury. The L-arginine/ADMA ratio was significantly decreased at 4–24 h after surgery in patients suffering myocardial injury. Conclusion: This explorative pathophysiological study showed that acute systemic endothelial dysfunction was present early after major emergency abdominal surgery and remained unchanged until day 3–5 after the procedure. Early postoperative disturbances in the nitric oxide bioavailability might add to the pathogenesis of myocardial injury. This pathophysiological link should be confirmed in larger studies. Trial registration: clinicaltrials.gov no. NCT03010969.